«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

26卷

期数:

2020年06期

页码:

533-537

栏目:

临床医学

出版日期:

2020-11-20

文章信息/Info

Title:

Study on relationship between hemoglobin and gout combined with nonalcoholic fatty liver disease

作者:

聂秀玲; 宋林凌; 孙丽荣

国家卫生健康委员会激素与发育重点实验室（天津医科大学）,天津市代谢性疾病重点实验室,天津医科大学朱宪彝 纪念医院，内分泌研究所痛风科，天津 300134

Author(s):

NIE Xiu-ling; SONG Lin-ling; SUN Li-Rong

NHC Key Laboratory of Hormones and Development（Tianjin Medical University）, Tianjin Key Laboratory of Metabolic Diseases, Department of Gout, Chu Hsien-I Memorial Hospital, Tianjin Medical University, Tianjin Institute of Endocrinology, Tianjin 300134, China

关键词:

痛风;  血红蛋白;  非酒精性脂肪性肝病;  胰岛素抵抗

Keywords:

gout; hemoglobin; non-alcoholic fatty liver disease; insulin resistance

分类号:

R589.7+R575.5

DOI:

-

文献标志码:

A

摘要:

目的：探讨痛风合并非酒精性脂肪性肝病（NAFLD）患者血红蛋白的特征以及血红蛋白水平与NAFLD的关系。 方法：选取住院痛风患者537例，行腹部超声检查,根据NAFLD程度（无、轻、中重度）分为单纯痛风组、痛风合并轻度 脂肪肝、痛风合并中重度脂肪肝3组。以血红蛋白水平四分位分组，Q1组（血红蛋白<135 g/L）、Q2组（135 g/L≤血 红蛋白＜145 g/Ｌ）、Q3组（145 g/L≤血红蛋白＜154 g/L)、Q4组（血红蛋白≥154 g/L）。测量身高、体重、腰围 、臀围、血压。抽取肘静脉血测血常规、总胆固醇、甘油三酯、高密度脂蛋白-胆固醇、低密度脂蛋白-胆固醇、肝酶 、尿素氮、肌酐、尿酸、糖化血红蛋白、血糖、胰岛素，计算稳态模型评估-胰岛素抵抗指数（HOMA-IR）。结果：3组 间一般资料比较显示，脂肪肝程度越重组年龄越小，体重指数、腰臀比越大；红细胞计数、血红蛋白、红细胞压积、 红细胞分布宽度标准差（SD）、红细胞分布宽度变异系数（CV）、甘油三酯、谷丙转氨酶、谷草转氨酶、γ转肽酶、 空腹血糖、糖化血红蛋白、血尿酸、HOMA-IR均随着脂肪肝程度的加重而明显升高 （F=3.08～34.85，均P<0.05）。病 程、累及关节数、血小板、血尿素氮、血肌酐、碱性磷酸酶随着脂肪肝的加重而下降（F=3.46～14.54，均P<0.05）。 血红蛋白水平与年龄、血尿素氮、血肌酐呈负相关（r=-0.153、-0.222、-0.134，均P<0.01）；血红蛋白水平与谷丙 转氨酶、谷草转氨酶、血尿酸、有无脂肪肝呈正相关（r=0.238、0.132、0.107、0.239，均P<0.01）。随着血红蛋白 水平升高，NAFLD患病率呈明显升高趋势，而NAFLD的病变程度呈加重趋势（χ2=25.57，P<0.001），Q1组~Q4组的 NAFLD总患病率分别为16.2%、18.43%、21.6%和20.48%；Logistic回归分析显示，随着血红蛋白水平的升高，发生 NAFLD的风险明显增大。以Q1组作对照，Q2组的OR值为1.410（95%CI：0.848～2.345），Q3组的OR值为2.087（95%CI： 1.619～4.532）, Q4组的OR值为3.113（95%CI：1.748～5.542），差异有统计学意义。调整年龄、性别因素后，Q4组 发生NAFLD的OR值为2.507（95%CI：1.382～4.548），差异仍有统计学意义。结论：痛风合并NAFLD患者的血红蛋白水 平随着NAFLD的严重程度而呈明显升高趋势；随着血红蛋白水平的升高，NAFLD呈显著上升趋势，进一步分析显示血红 蛋白水平与NAFLD的发生有独立相关性。

Abstract:

Objective: To investigate the features of hemoglobin in gout combined with nonalcoholic fatty liver diseases(NAFLD) and the relationship between hemoglobin and NAFLD. Methods: A total of 537 patients with gout were enrolled. All patients underwent abdominal ultrasonography. According to the degree of NAFLD, the patients were divided into simple gout group, gout combined with mild NAFLD group and gout combined with moderate-severe NAFLD group. According to hemoglobin tetrad, all patients were divided into Q1 group(hemoglobin<135 g/L), Q2 group (135 g/L≤hemoglobin＜145 g/L), Q3 group (145 g/L≤ hemoglobin＜154 g/L), Q4 group (hemoglobin≥154 g/L). Height, weight, waist, hip and blood pressure were measured. Extracting the elbow venous blood, blood biochemistry parameters were measured, including blood routine examination, total cholesterol, triglyceride, high-density lipoprotein- cholesterol, low-density lipoprotein-cholesterol, liver enzyme, urea nitrogen, creatinine, uric acid, glycated hemoglobin, fasting plasma glucose, insulin. Homeostasis model evaluation- insulin resistance index (HOMA-IR) was calculated. Results: The comparison of general data among the three groups showed that the more serious the degree of NAFLD, the younger the age, the higher the BMI and waist-hip ratio. Red blood cell count, hemoglobin, hematocrit, red blood cell distribution width SD, red blood cell distribution width CV, triglyceride, alanine transaminase, aspertate aminotransferase, gamma transpeptidase, fasting plasma glucose, glycosylated hemoglobin, serum uric acid and HOMA-IR increased with the aggravation of NAFLD(F = 13.08-34.85, all P<0.05). Course of gout, the number of joints involved, platelet, serum urea nitrogen, serum creatinine and alkaline phosphatase(ALP) were decreased with the aggravation of NAFLD(F = 3.46-14.54, all P<0.05). Hemoglobin was negatively related to age, serum urea nitrogen and serum creatine（r value was -0.153, -0.222, -0.134 respectively，all P<0.01） and positively with serum uric acid, alanine transaminase, aspertate aminotransferase and NAFLD(r value was 0.238, 0.132, 0.107, 0.239，respectively, all P<0.01). The results showed that the prevalence of NAFLD was increased with increasing hemoglobin, and the degree of NAFLD became more serious( χ2=25.57 ，P<0.001). The overall prevalence of NAFLD in Q1-Q4 groups was 16.2%，18.43%，21.6%, and 20.48%, respectively. Logistic regression showed that the risk of NAFLD was increased with the increase of hemoglobin, Taking Q1 group as a control, OR of Q2 group was1.41(95%CI： 0.848-2.345), OR of Q3 group was 2.087(95%CI： 1.619-4.532), OR of Q4 group was 3.113(95%CI: 1.748-5.542). After adjusting for age and gender, OR of NAFLD in Q4 group was 2.507(95% CI: 1.382-4.548), and the difference was still statistically significant. Conclusion: The serum hemoglobin of gout combined with NAFLD increases with the severity of NAFLD. NAFLD shows a significant upward trend with the increase of hemoglobin level. Further analysis shows that serum hemoglobin is independently associated with the occurrence of NAFLD.

参考文献/References:

[1] Lucero D，Miksztowics V，Gualano G，et al. Nonalcoholic fatty liver disease associated with metabolic syndrome：influence of liver fibrosis stages on characteristics of very low-density lipoproteins [J].Clin Chim Acta，2017，473（9）：1
[2] Katsiki N，Perez-Martinez P, Anagnostis P, et al. Is nonalcoholic fatty liver disease indeed the hepatic manifestation of metabolic syndrome? [J]. Curr Vasc Pharmacol，2018，16（3）：219
[3] Das S K，Musherjee S，Vasudevan D M，et al. Comparison of haemotological parameter in patients with non-alcoholic fatty liver disease and alcoholic disease[J]. Sigapore Med J，2011，52（3）：175
[4] Radmard A R，Poustchi H，Dadgostar M，et al. Liver enzyme levels and hepatic iron content in fatty liver：a noninvasive assessment in general population by T2*mapping[J]. Acad Radiol， 2015， 22（ 6）：714
[5] Adams L A，Crawford D H，Stuart K，et al. The impact of phlebotomy in nonalcoholic fatty liver disease：prospective，randomized，controlled trial[J]. Hepatology，2015，61（5）：1555
[6] 杨雪，刘磊，朱小霞，等.2015年美国风湿病学会/欧洲抗风湿病联盟痛风诊断评述 [J].中华风湿病学杂志， 2016，20（2）：141
[7] Fan J G，Jia J D，Li Y M，et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease：update 2010[J] . J Dig Dis，2011，12（1）：38
[8] Bellentani S.The epidemiology of nonalcoholic fatty liver disease [J]. Liver Int， 2016，37 （Suppl 1）：81
[9] Di Bonito P，Valerio G，Licenziati M R，et al. High uric acid，reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity [J]. J Endocrinol Invest，2020，43（4）：461
[10] Luero D，Miksztowics V，Gualano G，et al. Nonalcoholic fatty liver disease associated with metabolic syndrome：influence of liver fibrosis stages on characteristics of very low-density lipoproteins[J]. Clin Chim Acta，2017，473（9）：1
[11] 郑路，许世跃.血红蛋白在老年非酒精性脂肪肝伴糖尿病患者中作为铁负荷相关指标临床研究 [J].医学前沿， 2013，4（2）：117
[12] Li Y，Liu L，Wang B，et al. Hematocrit is associated with fibrosis in patients with nonacoholic steatohepatitis[J]. Eur J Gastroenterol Hepatol，2014，26（7）：330
[13] Akyuz U，Yesil A，Yilmaz Y. Characterization of lean patients with nonalcoholic fatty liver disease：potential role of high hemoglobin levels [J]. Scand J Gastroenterol，2015，50（3）：341
[14] Bai C H，Wu M S，Owaga E，et al. Relationship between hemoglobin levels and risk for suspected non-alcoholic fatty liver in Taiwanese adults [J]. Clin J Physiol，2014，57（5）：286
[15] Yu C，Xu C，Xu L，et al. Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease[J]. J Hepatol，2012，56（1）：241
[16] Luero D，Miksztowics V，Gualano G，et al. Nonalcoholic fatty liver disease associated with metabolic syndrome：influence of liver fibrosis stages on characteristics of very low-density lipoproteins [J]. Clin Chim Acta，2017，473（9）：1
[17] Ghamarchehreh M E，Jonaidi-Jafari N，Bigdeli M，et al. Iron status and metabolic syndrome in patients with non-alcoholic fatty liver disease[J]. Middle East J Dig Dis，2016，8（1）：31

相似文献/References:

[1]郭彩云,聂秀玲,孙丽荣,等.高尿酸血症/痛风与非酒精性脂肪肝严重程度的相关研究[J].天津医科大学学报,2013,19(06):499.
　GUO Cai-yun,NIE Xiu-ling,SUN Li-rong,et al.Hyperuricemia or gout associated with the severity of nonalcoholic fatty liver disease[J].Journal of Tianjin Medical University,2013,19(06):499.

备注/Memo

备注/Memo:

文章编号 1006-8147（2020）06-0533-05
作者简介 聂秀玲（1969-）, 副主任医师，博士，研究方向：糖尿病、痛风及相关并发症；E- mail:niexiuling001@126.com。

常用功能

更新日期/Last Update: 2020-11-20